Sequent Scientific has received board’s approval for investment of up
to Rs 150 crore in the equity capital/ convertible warrants of Shasun
Pharmaceuticals. The investment is subject to statutory and other
approvals, as may be applicable, including approval of shareholders
under section 186 of the Companies Act, 2013.For more information ✆ - 0731-6642300 or Visit https://www.epicresearch.co/
No comments:
Post a Comment